Other Solid Tumors
Glioblastoma multiforme
Glioblastoma multiforme (GBM) is a fast growing and highly malignant type of tumor that forms from glial tissue of the brain and spinal cord. GBM is the most common primary brain tumor in adults, with approximately 10,000 new U.S. patients diagnosed with GBM in 2008. The standard of care for GBM is palliative and includes chemotherapy, radiotherapy and surgery. Median survival is under 15 months. No significant advancements in the treatment of GBM have occurred in the past 25 years.
Uterine cancer
Uterine cancer, sometimes called endometrial cancer, is one of the most common cancers in American women. The cancer begins in the cells of the endometrium, the lining of the uterus, and occurs most often in women around age 60. In 2008, an estimated 40,000 new cases of uterine cancer were diagnosed in the U.S., with approximately 7,000 deaths attributed to the disease. Uterine cancer is often detected during an early stage because it is frequently associated with early symptoms such as abnormal vaginal bleeding. Surgery is the most common treatment for uterine cancer.
Pancreatic cancer
Pancreatic cancer occurs when there is an uncontrolled growth of abnormal cells in the pancreas or ducts carrying pancreatic fluids. Each year, more than 30,000 people are diagnosed with pancreatic cancer in the U.S. Approximately 15 percent of patients with pancreatic cancer are diagnosed with a localized form of the disease that is suited for surgical treatment. Most patients are diagnosed with an advanced form of the disease and survive for less than one year. An approved standard of care that can treat pancreatic cancer remains a major unmet need in oncology.
Glioblastoma multiforme (GBM) is a fast growing and highly malignant type of tumor that forms from glial tissue of the brain and spinal cord. GBM is the most common primary brain tumor in adults, with approximately 10,000 new U.S. patients diagnosed with GBM in 2008. The standard of care for GBM is palliative and includes chemotherapy, radiotherapy and surgery. Median survival is under 15 months. No significant advancements in the treatment of GBM have occurred in the past 25 years.
More information on GBMResources on glioblastoma multiforme
National Cancer Institute: "What You Need to Know About Brain Tumors"
American Society of Clinical Oncology
American Cancer Society: "What Are Brain and Spinal Cord Tumors?"
BiPar Sciences is evaluating BSI-201 as a potential new targeted therapy for malignant glioma.
For more information about BiPar Sciences' clinical trial in GBM, visit clinicaltrials.gov.
Uterine cancer
Uterine cancer, sometimes called endometrial cancer, is one of the most common cancers in American women. The cancer begins in the cells of the endometrium, the lining of the uterus, and occurs most often in women around age 60. In 2008, an estimated 40,000 new cases of uterine cancer were diagnosed in the U.S., with approximately 7,000 deaths attributed to the disease. Uterine cancer is often detected during an early stage because it is frequently associated with early symptoms such as abnormal vaginal bleeding. Surgery is the most common treatment for uterine cancer.
- More information on uterine cancer
Resources on uterine cancer
National Cancer Institute
American College of Obstetricans and Gynecologists
American Society of Clinical Oncology
American Cancer Society: "What Is Endometrial Cancer?"
American Cancer Society: "All About Endometrial Cancer"
BiPar Sciences is evaluating BSI-201 as a potential new targeted therapy for uterine cancer.
For more information about BiPar Sciences' clinical trial in uterine cancer, visit clinicaltrials.gov.
Pancreatic cancer
Pancreatic cancer occurs when there is an uncontrolled growth of abnormal cells in the pancreas or ducts carrying pancreatic fluids. Each year, more than 30,000 people are diagnosed with pancreatic cancer in the U.S. Approximately 15 percent of patients with pancreatic cancer are diagnosed with a localized form of the disease that is suited for surgical treatment. Most patients are diagnosed with an advanced form of the disease and survive for less than one year. An approved standard of care that can treat pancreatic cancer remains a major unmet need in oncology.
- More information on pancreatic cancer
Resources on pancreatic cancer
National Cancer Institute
American Society of Clinical Oncology
American Cancer Society
BiPar Sciences is evaluating BSI-201 as a potential new targeted therapy for pancreatic cancer.
For more information about BiPar Sciences' clinical trials in pancreatic cancer, visit clinicaltrials.gov.